To fund clinically relevant basic science and clinical research to
eliminate retinopathy of prematurity and associated retinal diseases.
To fund innovative work leading directly to the development of new
low vision devices and teaching techniques and services for children who
are visually impaired and their families.
ROPARD’s 2008 Children’s Vision Award Dinner
Saturday May 31, 2008
The new Detroit Institute of Arts
The
Children’s Vision Award was established in 2000 to honor people who have
made a significant contribution to improving children’s vision through
pediatric retinal research and education.
This year, ROPARD will honor Dr. Mark Humayun, Professor of
Ophthalmology at the Keck School of Medicine and Associate Director of
Research at the Doheny Eye Institute at the University of Southern
California, for his work on retinal implants and in recognition of his
lifelong desire to help the blind to see.
Our
keynote speaker for this event will be Ray Kurzweil. Mr. Kurzweil is an
inventor, entrepreneur, visionary, futurist, philosopher, and author.
His latest book, The Singularity is Near will be available for purchase
at our event.
Mr. Kurzweil has been involved in providing assistive devices for the
blind for many years. His Kurzweil Reading Machine developed over three
decades ago, has recently been replaced with the Kurzweil-NFB Reader,
the world’s first handheld optical character recognition reading
system.
Today
Ray Kurzweil continues to expand his explorations into the limitations
of biology on technological advancement and how this will affect the
future of the human species. Mr. Kurzweil will appear as an interactive
hologram at the Children’s Vision Award.
For more information or to
register
now for the event please
Click Here.
Saturday May 31, 2008
Location:
The new Detroit Institute
of Arts
5200 Woodward Avenue
Detroit, MI 48202
Map to the event
Register Now
Presented by
Associated Retinal Consultants, P.C.
In cooperation with
ROPARD
Sponsored by Beaumont©
A Vision of the Future 2008 Pediatric and Adult Retina Update
Friday and Saturday, May 30 and 31,
2008
Dearborn Inn
Dearborn, Michigan
Course Description
This CME activity will offer ophthalmologists practical
approaches to the management of contemporary issues encountered in
today’s clinical populations. The conference has been designed to expand
on recent research and treatment modalities for pediatric retina,
retinal vascular disease, retinitis pigmentosa, macular degeneration,
diabetic retinopathy and other management schemes including
pharmacotherapy as well as new diagnostic technology.
Target Audience Comprehensive ophthalmologists, retinal specialists,
residents and fellows.
Program Objectives
Following attendance at this program, the participant should be able
to:
- Decrease complications associated with ROP by utilizing the most
current ROP management techniques in clinical practice
- Analyze the pros and cons of telemedicine for pediatric retinal
disease in order to individualize treatment plans for their
pediatric patient population
- Incorporate the applications of anti-VEGF drugs for adult and
pediatric diseases into their diagnostic, screening, and therapeutic
regimes
Accreditation and Credit
William Beaumont Hospital is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
William Beaumont Hospital designates this educational activity for a
maximum of 11.75 AMA PRA Category 1 credit(s)™. Physicians should only
claim credit commensurate with the extent of their participation in the
activity. Participants who sign in and complete a request for
certificate will receive their certificate of credit via US mail within
four weeks of the conference.
Evaluation
All participants are requested to complete a post-conference
evaluation that will be used to review this activity and to identify
future educational needs. Disclosure Statement All faculty and planning
committee members have been asked to disclose any financial
relationships they may have with commercial companies and also if they
will be discussing the off-label use of any products. This information
will be made available at the time of the meeting.
Course Schedule
Pediatric Retinal Disease Management Program Schedule – Friday, May
30
Recent Advances in Retinal Disease Program Schedule – Saturday, May 31
For a Detailed Printable Schedule
Click Here
Register Now
Pre-registration is requested, as space is limited.
Registrations accepted on a first-come, first-served basis.
Registration Deadline: Please register before May 19,
2008.
Additional Information
|
Location
The Dearborn Inn
20301 Oakwood Blvd.
Dearborn, MI 48124
Phone: 313.271.3281
Fax: 313.271.6682
For directions:
Click Here |
Overnight Accommodations
Overnight accommodations are beingheld at The
Dearborn Inn, a Marriott Hotel, for the ROPARD Medical Meeting
at a special rate of $129/night (no breakfast included).
To make reservations, please call their toll
free number 877.757.7103 and state that you are with the
conference. If making reservations on-line, use group code
rmmrmma.
Reservations must be made by May 8 to assure the
special rate. Check-in is at 4 p.m. and check-out is at noon.
|
Guest Faculty
David K. Coats, M.D. Chief of Ophthalmology Texas
Children’s Hospital Prof. of Ophthalmology and Pediatrics Baylor College
of Medicine William V. Good, M.D. Principle Invesigator The Smith-Kettlewell
Eye Research Institute Practicing Ophthalmologist San Francisco’s
California Pacific Medical Center
ROPARD Lecturer
Mark S. Humayun, M.D., Ph.D. Professor of
Ophthamology Keck School of Medicine University of Southern California
Associated Retinal Consultants Faculty
Thomas M. Aaberg, Jr., M.D. Antonio Capone, Jr., M.D.
Kimberly A. Drenser, M.D., Ph.D. Alan J. Ruby, M.D. Michael T. Trese,
M.D.
Acknowledgement
Beaumont and Associated Retinal Consultants, P.C.
gratefully acknowledge the support of the Beaumont Foundation to this
educational activity.
Presented by
Associated Retinal Consultants, P.C.
In cooperation with
ROPARD
Sponsored by Beaumont©
ROPARD is The Association for Retinopathy of Prematurity and Related
Diseases (ROP). Our mission is to eliminate retinopathy of prematurity and associated retinal diseases.
